Turner Bredrup
Get their honest, personalized take on your startup.
Sign in to pitch Turner →At a glance
- Full Name
- Turner Ashby Moncure Bredrup Jr.
- Title
- Senior Advisor (formerly Managing Director & Group Head, Healthcare & Life Sciences)
- Firm
- Harris Williams
- Firm Type
- M&A / investment banking advisory firm (not a venture or angel fund — see note below)
- Investment Stage
- N/A — advises on control-stage M&A transactions (buyouts, sales, recapitalizations), not seed/early-stage equity
- Sector Focus
- Healthcare & Life Sciences — medical devices, medical device contract manufacturing, outsourced pharma services and pharma tech
- Geographic Focus
- United States (global deal reach through Harris Williams)
- Location
- Richmond, Virginia
Background
Turner Bredrup is a Senior Advisor at Harris Williams, the M&A advisory firm, where he spent decades in and eventually led the firm's Healthcare & Life Sciences practice. He is based in Richmond, Virginia, and is registered as a broker with the firm (FINRA CRD record under the name Turner Ashby Moncure Bredrup Jr.). Over a 35-plus-year career in investment banking he built a reputation advising owners of healthcare and life sciences businesses on sales, buyouts, and recapitalizations.
He earned a BA in History from the University of Virginia (1984–1988) and an MBA from UVA's Darden School of Business (1992–1994). Before joining Harris Williams in 1998, he worked as a Vice President at J.P. Morgan & Co. (1994–1998).
At Harris Williams, Bredrup has focused on the healthcare and life sciences sector, with particular depth in medical devices, medical device contract manufacturing, and outsourced pharma services and pharma tech. He has authored and co-authored the firm's industry insight pieces (including a two-part series on medical device contract manufacturing) and has spoken publicly about sector M&A trends. He was interviewed on The Investment Banking Leaders Podcast ("From Analyst to Industry Leader") on building trust, teams, and a top-tier M&A franchise.
Investment Thesis & Focus
- This is advisory, not venture investing. Bredrup's "yes" is about representing sellers and buyers in control M&A within healthcare/life sciences — not writing checks into startups.
- Sector concentration: Healthcare & Life Sciences, with hands-on expertise in medical devices, medical device contract manufacturing/outsourcing, and outsourced pharma services & pharma tech.
- Market view: He has publicly framed healthcare and life sciences as combining "fast-paced innovation with steadily growing demand," creating a broad, durable pipeline of M&A opportunities — the thesis underpinning his practice.
- Deal profile: Mid-market, sponsor- and strategic-driven transactions (sales to private equity and strategic acquirers, and PE-backed acquisitions).
Notable Investments
- Laborie Medical Technologies — advised on its sale to Patricia Industries (medical devices).
- Tri-Imaging Solutions — advised on its sale to DirectMed Imaging (medical imaging parts/service).
- Reliable Medical — advised on its sale to Gauge Capital (complex rehab / home medical equipment).
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.